Ligand Pharmaceuticals stock trades on Nasdaq, with Citigroup issuing buy ratings and a director selling shares.
2 reports, 1 independent
Updated Jul 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ligand Pharmaceuticals stock trades on Nasdaq, with Citigroup issuing buy ratings and a director selling shares.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California
-
Nasdaq
American fully electronic stock exchange
- Ongoing conflict in the Middle East is causing energy shocks, driving policy decisions, and leading to market exuberance affecting companies like Nvidia and those listed on Nasdaq.
- Global investor interest in India is growing, driven by the country's economic growth and attracting international companies.
-
SEC
Slovak company
Related events
- CleanSpark traded on the Nasdaq stock exchange, and Citigroup provided research reports and ratings.
- Corvus Pharmaceuticals began trading on the Nasdaq exchange on August 1, 2026.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
- City Holding Co. traded on the Nasdaq stock exchange today.
- PureCycle Technologies, Inc. traded on the Nasdaq stock exchange, and a director purchased company stock.